109 related articles for article (PubMed ID: 2342075)
21. Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue.
Andresen TL; Jensen SS; Madsen R; Jørgensen K
J Med Chem; 2005 Nov; 48(23):7305-14. PubMed ID: 16279790
[TBL] [Abstract][Full Text] [Related]
22. Membrane damage in leukemic cells induced by ether and ester lipids: an electron microscopic study.
Noseda A; White JG; Godwin PL; Jerome WG; Modest EJ
Exp Mol Pathol; 1989 Feb; 50(1):69-83. PubMed ID: 2920821
[TBL] [Abstract][Full Text] [Related]
23. Isosteric phosphonate analogs of ET-16-OMe. Synthesis and biological evaluation of the enantiomers of 2'-(trimethylammonio)ethyl 4-(hexadecyloxy)-3-methoxybutanephosphonate and 2'-(trimethylammonio)ethyl 4-(hexadecylthio)-3-methoxybutanephosphonate.
Bittman R; Byun HS; Mercier B; Salari H
J Med Chem; 1994 Feb; 37(3):425-30. PubMed ID: 8308870
[TBL] [Abstract][Full Text] [Related]
24. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
Wagner BA; Buettner GR; Burns CP
Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
[TBL] [Abstract][Full Text] [Related]
25. [Synthesis of p-substituted benzoylaminobenzoic acid (methyl esters) and its differentiation induction in activities of human promyelocytic leukemia cells HL-60].
Yu B; Xu P; Zeng Z
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):30-4. PubMed ID: 8070767
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel aliphatic amido-quaternary ammonium salts for anticancer chemotherapy: part I.
Yang JS; Song D; Lee B; Ko WJ; Park SK; Won M; Lee K; Kim HM; Han G
Eur J Med Chem; 2011 Jul; 46(7):2861-6. PubMed ID: 21543141
[TBL] [Abstract][Full Text] [Related]
27. Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells.
Hochhuth C; Berkovic D; Eibl H; Unger C; Doenecke D
J Cancer Res Clin Oncol; 1990; 116(5):459-66. PubMed ID: 1699946
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
Marino-Albernas JR; Bittman R; Peters A; Mayhew E
J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
[TBL] [Abstract][Full Text] [Related]
29. [Studies on compounds of cancer chemoprevention: synthesis of some amides].
Yuan ZL; Xu SP
Yao Xue Xue Bao; 1994; 29(6):468-70. PubMed ID: 7992627
[TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of phosphocholine and quaternary ammonium containing lipids as novel anti-HIV agents.
Meyer KL; Marasco CJ; Morris-Natschke SL; Ishaq KS; Piantadosi C
J Med Chem; 1991 Apr; 34(4):1377-83. PubMed ID: 2016713
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase C is not involved in cholesterol-induced resistance to synthetic ether lipids.
Diomede L; Salmona M; Lamorte G; Piovani B; Sozzani S
Anticancer Res; 1993; 13(5A):1331-4. PubMed ID: 8239503
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of ether-linked analogues of lysophosphatidate and their effect on the proliferation of human epithelial cancer cells in vitro.
Ashagbley A; Samadder P; Bittman R; Erukulla RK; Byun HS; Arthur G
Anticancer Res; 1996; 16(4A):1813-8. PubMed ID: 8712705
[TBL] [Abstract][Full Text] [Related]
33. Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
Magistrelli A; Villa P; Benfenati E; Modest EJ; Salmona M; Tacconi MT
Drug Metab Dispos; 1995 Jan; 23(1):113-8. PubMed ID: 7720513
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 1-O-alkyl-2-O-methyl-glycerophospholipids with potential antitumor activity.
Alunni-Bistocchi G; Orvietani PL; Ricci A; Binaglia L; Orlando M; Orlando P
Farmaco; 1990 May; 45(5):499-509. PubMed ID: 2222722
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
Hoffman DR; Hoffman LH; Snyder F
Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of proliferation and induction of differentiation of human and mouse myeloid leukemia cells by new ethyleneglycol-type nonphosphorus alkyl ether lipids.
Kasukabe T; Honma Y; Hozumi M; Nomura H
Jpn J Cancer Res; 1990 Aug; 81(8):807-12. PubMed ID: 2118893
[TBL] [Abstract][Full Text] [Related]
38. Undifferentiated HL-60 cells internalize an antitumor alkyl ether phospholipid more rapidly than resistant K562 cells.
Tsutsumi T; Tokumura A; Kitazawa S
Biochim Biophys Acta; 1998 Feb; 1390(1):73-84. PubMed ID: 9487142
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of novel aliphatic amido/sulfonamido-quaternary ammonium salts as antitumor agents.
Song D; Yang JS; Kim SJ; Kim BK; Park SK; Won M; Lee K; Kim HM; Choi KY; Lee K; Han G
Bioorg Med Chem; 2013 Feb; 21(3):788-94. PubMed ID: 23266181
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
Wagner BA; Buettner GR; Oberley LW; Burns CP
Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
